What are superantigens?

The Comprehensive Sourcebook of Bacterial Protein Toxins

Volumn , Issue , 2006, Pages 821-829

  Alouf, Joseph E ^a   Müller Alouf, Heide ^b  

^a INSTITUT PASTEUR   (France)

^b Domaine de la Ronce   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70450199848     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088445-2/50054-8     Document Type: Chapter

References (122)

1. Abe J., Forrester J., Nakahara T., Lafferty J.A., Kotzin B.L., Leung D.Y.M. Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B. J. Immunol. 1991, 146:3747-3750.
2. Akatsuka H., Imanishi K., Inada K., Yamashita T., Yoshida M., Uchiyama T. Production of tumor necrosis factors by human T cells stimulated by a superantigen, toxic shock syndrome toxin-1. Clin. Exp. Immunol. 1994, 96:422-426.
3. Alouf J.E. Streptococcal toxins. Streptolysin O, streptolysin S, erythrogenic toxins. Pharmacol. Therap. 1980, 11:661-717.
4. Alouf J.E., Müller-Alouf H., Köhler W. Superantigenic Streptococcus pyogenes erythrogenic pyrogenic exotoxins. The Comprehensive Sourcebook of Bacterial Protein Toxins 1999, 567-568. Academic Press. J.E. Alouf, J.H. Freer (Eds.).
5. Alouf J.E., Müller-Alouf H. Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects. Int. J. Med. Microbiol. 2003, 292:429-440.
6. Alouf J.E., Müller-Alouf H. Streptococcus group A. Encyclopedia of Diagnostic Genomics and Proteomics 2004, 1-5. Marcel Dekker Inc., London.
7. Arad G., Hillman D., Levy R., Kaempfer R. Broad-spectrum immunity against superantigens is elicited in mice protected from lethal shock by a superantigen antagonist peptide. Immunol. Lett. 2004, 91:141-1455.
8. Arcus V.L., Proft T., Sigrell J.A., Baker H.M., Fraser J.D., Baker E.N. Conservation structures of two new superantigens from Streptococcus pyogenes. J. Mol. Biol. 2000, 299:157-168.
9. Artiushin S.C., Timoney J.F., Sheoran A.S., Muthupalani S.K. Characterization and immunogenicity of pyrogenic mitogens SePE-H and SePE-I of Streptococcus equi. Microb. Pathogen. 2002, 32:71-85.
10. Arvand M., Schneider T., Jahn J.U., Hahn H. Streptococcal toxic shock syndrome associated with marked γδ T cell expansion: case report. Clin. Infect. Dis. 1996, 22:362-365.
11. Baker M.D., Acharya K.R. Superantigens structure-function relationships. Int J. Med Microbiol. 2004, 293:529-537.
12. Baker H.M., Proft T., Webb P.D., Arcus V.L., Fraser J.D., Baker E.N. Crystallographic and mutational data show that the streptococcal pyrogenic exotoxin J (SPE-J) can use a common binding surface for T cell receptor binding and dimerization. J. Biol. Chem. 2004, 279:38571-38576.
13. Beres S.B., Sylva G.L., Barbian K.D., Lei B., Hoff J.S., Mammarella N.D., Liu M.Y., Smoot J.C., Porcella S.F., Parkins L.D., Campbell D.S., Smith T.M., McCormick J.K., Leung D.Y., Schlievert P.M., Musser J.M. Genome sequence of a serotype M3 strain of group A streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc. Natl. Acad. Sci. USA. 2002, 99:10078-10083.
14. Bernal A., Proft T., Fraser J.D., Posnett D.N. Superantigens in human disease. J. Clin. Immunol. 1999, 19:149-157.
15. Bisno A.L., Brito M.O., Collins M.O. Molecular basis of group A streptococcal virulence. The Lancet Infect. Dis. 2003, 3:191-200.
16. Bowness P., Moss P.A.H., Tranter H., Bell J.I., McMichael J. Clostridium perfringens enterotoxin is a superantigen reactive with human T cell receptors Vβ 6.9 an Vβ 22. J. Exp. Med. 1992, 176:893-896.
17. Carlsson R., Fischer H., Sjögren H.O. Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells. J. Immunol. 1988, 140:2484-2488.
18. Cavaillon J.-M., Rivière Y., Svab J., Montagnier L., Alouf J.E. Induction of interferon by Streptococcus pyogenes extracellular products. Immunol. Lett. 1982, 5:323-326.
19. Champagne E., Huchenq A., Sevin J., Casteran N., Rubin B. An alternative method for T cell repertoire analysis: clustering of human V-beta subfamilies selected in response to straphylococcal enterotoxins B and E. Mol. Immunol. 1993, 30:877-886.
20. Choi Y., Kotzin B., Hernon L., Callahan J., Marrak P., Kappler K. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc. Natl. Acad. Sci. USA 1989, 86:8941-8945.
21. Choi Y.W., Herman A., DiGusto D., Wade T., Marrack P., Kapler J. Residues of the variable region of the T cell receptor beta-chain that interacts with S. aureus toxin superantigens. Nature 1990, 346:471-473.
22. Cole B.C., Daynes R.A., Ward J.R. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. I. Transformation is associated with an H-2-linked gene that maps to the I-E/I-C subregion. J. Immunol. 1981, 127:1931-1936.
23. Cole B.C., Atkin C.A. The Mycoplasma arthritidis T cell mitogen, MAM: a model superantigen. Immunol. Today 1991, 12:271-276.
24. Cole B.C., Knudston K.L., Oliphant A., Sawitzke A.D., Pole A., Manohar M., Benson L.S., Ahmed E., Atkin C.L. The sequence of the Mycoplasma arthritidis superantigen, MAM: identification of functional domains and comparison with microbial superantigens and plant lectin mitogens. J. Exp. Med. 1996, 183:1105-1110.
25. Cole B.C., Sawitzke A.D., Ahmed E.A., Atkin C.L., David C.S. Allelic polymorphisms at the H-2A and HLA-DQ loci influence the response of murine lymphocytes to the Mycoplasma arthritidis superantigen MAM. Infect. Immun. 1997, 65:4190-4198.
26. Conrad B., Weissmahr R.N., Boni J., Arcari R., Schupbach J., Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 1997, 90:303-313.
27. Dellabona P., Peccoud J., Kappler J., Marrack P., Benoist C., Mathis D. Superantigens interact with MHC class II molecules outside of the antigen groove. Cell 1990, 62:1115-1121.
28. Deresiewicz R.L., Woo J.H., Chan M., Finberg R.W., Kasper D.L. Mutations affecting the activity of toxic shock syndrome toxin. Biochemistry 1994, 33:12844-12851.
29. Fast D.J., Schlievert P.M., Nelson R.D. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect. Immun. 1989, 57:291-294.
30. Ferretti J.J., McShan W.M., Ajdic D., Savic G., Lyon K., Primeaux C., Sezate S., Suvorov A.N., Kenton S., Lai H.S., Lin S.P., Qian Y., Jia H.G., Najar F.Z., Ren Q., Zhu H., Song L., White J., Yuan X., Clifton S.W., Roe B.A., McLaughlin R. Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc. Natl. Acad. Sci. USA 2001, 98:4658-4663.
31. Fischer H., Dohlsten M., Andersson U., Hedlund G., Ericsson P., Hansson J., Sjögren H.O. Production of TNFα and TNF& by staphylococcal enterotoxin A activated human T cells. J. Immunol. 1990, 144:4663-4668.
32. Fleischer B., Schrezenmeier H. T cell stimulation by staphylococcal enterotoxins. J. Exp. Med. 1988, 167:1697-1707.
33. Fleischer B., Schrezenmeier H., Conrad P. T lymphocyte activation by staphylococcal enterotoxins: role of class II molecules and T cell surface structures. Cell. Immunol. 1989, 120:92-101.
34. Florquin S., Aaldering L. Superantigens: a tool to gain new insight into cellular immunity. Res. Immunol. 1997, 148:373-386.
35. Fraser J.D. High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature 1989, 339:221-223.
36. Fraser J., Arcus V., Kong P., Baker E., Proft T. Superantigens-powerful modifiers of the immune system. Mol. Med. Today 2000, 6:125-132.
37. Hackett S.P., Stevens D.L. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor β synthesis. J. Infect. Dis. 1993, 168:232-235.
38. Hensler T., Köller M., Geoffroy C., Alouf J.E., König W. Staphylococcus aureus toxic shock syndrome toxin 1 and Streptococcus pyogenes erythrogenic toxin A modulate inflammatory mediator release from human neutrophils. Infect. Immun. 1993, 61:1055-1061.
39. Hodstev A.S., Choi Y., Spanoupoulo E., Posnett D.N. Mycoplasma superantigen is a CDR3-dependent ligand for the T cell antigen receptor. J. Exp. Med. 1998, 187:319-327.
40. Huber B.T., Hsu P-N., Sulkowski N. Virus-encoded superantigens. Microbiol. Rev. 1996, 60:473-483.
41. Igwe E.I., Shewmaker P.L., Facklam R.R., Farley M.M., van Beneden C., Beall B. Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans. FEMS Microbiol. Lett. 2003, 229:259-264.
42. Imanishi K., Igarashi H., Uchiyama T. Relative abilities of distinct isotypes of human major histocompatibility complex class II molecules to bind streptococcal pyrogenic exotoxins types A and B. Infect. Immun. 1992, 60:5025-5029.
43. Jarraud S., Cozon G., Vandenesch F., Bes M., Etienne J., Lina G. Involvement of enterotoxins G and I in staphylococcal toxic shock syndrome and staphylococcal scarlet fever. J. Clin. Microbiol. 1999, 37:2446-2449.
44. Jupin C., Anderson S., Damais C., Alouf J.E., Parant M. Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon. J. Exp. Med. 1988, 167:752-761.
45. Kamezawa Y., Nakahara T., Nakano S., Abe Y., Nozaki-Renard J. Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes. Infect. Immun. 1997, 65:3828-3833.
46. Kappler J., Kotzin B., Herron L., Gelfand E., Bigler R., Boylston A., Carrel S., Posnett D., Choi Y., Marrack P. Vβ specific stimulation of human T cells by staphylococcal toxins. Science 1989, 244:811-813.
47. Kikuchi K., Takahashi N., Piao C., Totsuka K., Nishida H., Uchiyama T. Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains causing neonatal toxic shock syndrome-like exanthematous disease in neonatal and perinatal wards. J. Clin. Microbiol. 2003, 41:3001-3006.
48. Kline J.B., Collins C.M. Analysis of the interaction between the bacterial superantigen streptococcal pyrogenic exotoxin A (SPEA) and the human T cell receptor. Mol. Microbiol. 1997, 24:197-202.
49. Kotb M. Superantigens in human diseases. Clin. Microbiol. Newslett. 1997, 19:145-152.
50. König B., Köller M., Prévost G., Piémont Y., Geoffroy C., Alouf J.E., Schreiner A., König W. Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin, erythrogenic toxin A): generation of interleukin-8. Infect. Immun. 1994, 62:4831-4837.
51. Krakauer T., Fleischer B.H., Stevens D.L., McClane B., Stiles B.G. Clostridium perfringens enterotoxin lacks superantigenic activity but induces an interleukin-6 response from human peripheral blood mononuclear cells. Infect. Immun. 1997, 65:3485-3488.
52. Krakauer T. Immune response to staphylococcal superantigens. Immunol. Res. 1999, 20:163-173.
53. Krakauer T., Stiles B.G. Staphylococcal enterotoxins, toxic shock syndrome toxin-1, and streptococcal pyrogenic exotoxins: some basic biology of bacterial superantigens. Rec. Res. Devel. Infection & Immunity 2003, 1:1-27.
54. Leung D.Y.M., Meissner H.C., Fulton D.R., Quimby F., Schlievert P.M. Superantigens in Kawasaki syndrome. Clin. Immunol. Immunopathol. 1995, 77:119-126.
55. Leung D.Y., Travers J.B., Giorno R., Norris D.A., Skinner R., Aelion J., Xaremi L.V., Kim M.H., Trumble A.E., Kotb M., Schlievert P.M. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J. Clin. Invest. 1995, 96:2106-2112.
56. Leung D.Y.M., Gately M., Trumble A., Ferguson-Darnell B., Schlievert P.M., Pickler L. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen via stimulation of IL-12. J. Exp. Med. 1995, 181:747-753.
57. Leung D.Y., Huber B.T., Schlievert P.M. Superantigens: Molecular Biology, Immunology, and Relevance to Human Disease 1997, eds., Marcel Dekker, New York.
58. Li H., Llera A., Malchiodi E.L., Mariuzza R.A. The structural basis of T cell activation by superantigens. Annu. Rev. Immunol. 1999, 17:435-466.
59. Lina G., Bohach G.A., Nair S.P., Hiramatsu K., Jouvin-Marche E., Mariuzza R. International Nomenclature Committee for staphylococcal superantigens. Standard nomenclature for the superantigens expressed by Staphylococcus. J. Infect. Dis. 2004, 189:2334-2336.
60. Llwelyn M., Cohen J. Superantigens: microbial agents that corrupt immunity. Lancet Infect. Dis. 2002, 2:156-162.
61. Llewelyn M., Sriskandan S., Peakman M., Ambrozak R., Douek D.C., Kwok W.W., Cohen J., Altmann D.M. HLA class II polymorphisms determine responses to bacterial superantigens. J. Immunol. 2004, 172:1719-1726.
62. Macphail S. Superantigens: mechanisms by which they may induce, exacerbate, and control autoimmune diseases. Int. Rev. Immunol. 1999, 18:141-180. (1999).
63. Mahlknecht U., Herter M., Hoffmann M.K., Niethammer D., Dannecker G.E. The toxic shock syndrome toxin-1 induces anergy in human T cells in vivo. Hum. Immunol. 1996, 45:42-45.
64. Marrack P., Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990, 248:705-711.
65. Matsuda Y., Kato H., Yamada R., Okano H., Ohta H., Imanishi K., Kikuchi K., Totsuka K., Uchiyama T. Early and definitive diagnosis of toxic shock syndrome by detection of marked expansion of T cell receptor Vβ2-positive T cells. Emerg. Infect. Dis. 2003, 9:387-389.
66. McCormick J.K., Pragman A.A., Stolpa J.C., Leung D.Y., Schlievert P.M. Functional characterization of streptococcal pyrogenic exotoxin J a novel superantigen. Infect. Immun. 2001, 69:1381-1388.
67. McCormick J.K., Yarwood J.M., Schlievert P.M. Toxic shock syndrome and bacterial superantigens: an update. Annu. Rev. Microbiol. 2001, 55:77-104.
68. Michie C., Scott A., Cheeseborough J., Bevereley P., Pasvol G. Streptococcal toxic-like shock syndrome: evidence of superantigen activity and its effects on T lymphocyte subsets in vivo. Clin. Exp. Immunol. 1994, 98:140-144.
69. Miethke T., Vabulas R., Bittlingermaier I.R., Heeg K., Wagner H. Mechanisms of peripheral T cell deletion: anergized T cells are Fas resistant but undergo proliferation associated apoptosis. Eur. J. Immunol. 1996, 26:1459-1467.
70. Miyoshi-Akoyama T., Zhao J., Kato H., Kikuchi K., Totsuka K., Kataoka Y., Katsumi M., Uchiyama T. Streptococcus dysgalactiae-derived mitogen (SDM), a novel bacterial superantigen: characterization of its biological activity and predicted tertiary structure. Mol. Microbiol. 2003, 47:1589-1599.
71. Mollick J., Cook R., Rich R. Class II MHC molecules are specific receptors for staphylococcal enterotoxin A. Science 1989, 244:817-819.
72. Mollick J.A., Miller G.G., Musser J.M., Cook R.G., Grossman D., Rich R.R. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J. Clin. Invest. 1993, 92:710-719.
73. Monday S.R., Bohach G.A. Properties of Staphylococcus aureus enterotoxins and toxic shock syndrome toxin-1. The Comprehensive Sourcebook of Bacterial Protein Toxins 1999, 589-610. Academic Press, New York. J.E. Alouf, J.H. Freer (Eds.).
74. Morita C.T., Li H., Lamphear J.G., Rich R.R., Fraser J.D., Mariuzza R.A., Lee K. Superantigen recognition by gamma delta T cells: SEA recognition site for human V gamma 2 T cell receptors. Immunity 2001, 14:331-344.
75. Mu H.H., Sawitzke A.D., Cole B.C. Presence of Lps(d) mutation influences cytokine regulation in vivo by the Mycoplasma arthritidis mitogen superantigen and lethal toxicity in mice infected with M. arthritidis. Infect. Immun. 2001, 69:3837-3844.
76. Müller-Alouf H., Alouf J.E., Gerlach D., Ozegowski J.-H., Fitting C., Cavaillon J.M. Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide. Infect. Immun. 1994, 62:4915-4921.
77. Müller-Alouf H., Alouf J.E., Gerlach D., Ozegowski J.-H., Fitting C., Cavaillon J.M. Human pro- and anti-inflammatory cytokine pattern induced by Streptococcus pyogenes erythrogenic (pyrogenic) exotoxins A and C superantigens. Infect. Immun. 1996, 64:1450-1453.
78. Müller-Alouf H., Gerlach D., Desreumaux P., Leportier C., Alouf J.E., Capron M. Streptococcal pyrogenic exotoxin A (SPE A) superantigen-induced production of hematopoietic cytokines, IL-12 and IL-13, by human peripheral blood mononuclear cells. Microb. Pathogen. 1997, 23:265-272.
79. Müller-Alouf H., Carnoy C., Simonet M., Alouf J.E. Superantigen bacterial toxins: state of the art. Toxicon 2001, 39:1691-1701.
80. Müller-Alouf H., Proft T., Zollner T.M., Gerlach D., Champagne E., Desreumaux P., Fitting C., Geoffroy-Fauvet C., Alouf J.E., Cavaillon J.M. Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A. Infect. Immun. 2001, 69:4141-4145.
81. Nadal D., Lauener R.P., Braegger C.P., Kaufhoid A., Simma B., Lütticken R., Seger A. T cell activation and cytokine release in streptococcal toxic shock-like syndrome. J. Pediatr. 1993, 122:727-729.
82. Norgren M., Eriksson A. Streptococcal superantigens and their role in the pathogenesis of severe infections. J. Toxicol. Toxin Rev. 1997, 16:1-32.
83. Norrby-Teglund A., Newton D., Kotb M., Holm S.E., Norgren M. Superantigenic properties of the group A streptococcal exotoxin SPE F (MF). Infect. Immun. 1994, 62:5227-5233.
84. Norrby-Teglund A., Pauksens K., Norgren M., Holm S.E. Correlation between serum TNF α and IL-6 levels and severity of group A streptococcal infections. Scand J. Infect Dis. 1995, 27:125-130.
85. Norrby-Teglund A., Chetellier S., Low D., McGeer A., Green K., Kotb M. Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur. J. Immunol. 2000, 30:3247-3255.
86. Norrby-Teglund A., Thulin P., Gan B.S., Kotb M., McGeer A., Andersson J., Low D.E. Evidence for superantigen involvement in severe group A streptococcal tissue infections. J. Infect. Dis. 2001, 184:853-860.
87. Omoe K., Imanishi K., Hu D.L., Kato H., Takahashi-Omoe H., Nakane A., Uchiyama T., Shinagawa K. Biological properties of staphylococcal enterotoxin-like toxin type R. Infect Immun. 2004, 72:3664-3667.
88. Orwin P.M., Leung D.Y., Donahue H.L., Novick R.P., Schlievert P.M. Biochemical and biological properties of staphylococcal enterotoxin K. Infect. Immun. 2001, 69:360-366.
89. Orwin P.M., Fitzgerald J.R., Leung D.Y., Gutierrez J.A., Bohach G.A., Schlievert P.M. Characterization of Staphylococcus aureus enterotoxin L. Infect. Immun. 2003, 71:2916-2919.
90. Parsonnet J., Hickman R.K., Eardley D.D., Pier G.B. Induction of human interleukin-1 by toxic shock syndrome toxin-1. J. Inf. Dis. 1985, 151:514-522.
91. Parsonnet J., Gillis Z.A. Production of tumor necrosis factor by human monocytes in response to toxic shock syndrome toxin-1. J. Inf. Dis. 1988, 158:1026-1033.
92. Petersson K., Petersson H., Skartved N.J., Walse B., Forsberg G. Staphylococcal enterotoxin H induces V alpha-specific expansion of T cells. J. Immunol. 2003, 170:4148-4154.
93. Petersson K., Forsberg G., Walse B. Interplay between superantigens and immunoreceptors. Scand. J. Immunol. 2004, 59:345-355.
94. Plano L.R., Gutman DM., Woischnik M., Collins CM. Recombinant Staphylococcus aureus exfoliative toxins are not bacterial superantigens. Infect Immun. 2000, 68:3048-3052.
95. Proft T., Moffat S.L., Fraser J.D. Identification and characterization of novel superantigens from Streptococcus pyogenes. J. Exp. Med. 1999, 189:89-102.
96. Proft T., Moffat S.L., Weller K.D., Paterson A., Martin D., Fraser J.D. The streptococcal superantigen SMEZ exhibits wide allelic variation, mosaic structure, and significant antigenic variation. J. Exp. Med. 2000, 197:1765-1767.
97. Proft T., Webb P.D., Handley V., Fraser J.D. Two novel superantigens found in both group A and group C streptococcus. Infect. Immun. 2003, 71:1361-1369.
98. Proft T., Sriskandan S., Yang L., Fraser J.D. Superantigens and streptococcal toxic shock syndrome. Emerg. Infect. Dis. 2003, 9:1211-1218.
99. Rink L., Luhm J., Koestler M., Kirchner H. Induction of a cytokine network by superantigens with parallel TH1 and TH2 stimulation. J. Interferon Cytokine Res. 1996, 16:41-47.
100. Rust C.J.J., Verreck F., Vietor H., Koning F. Specific recognition of staphylococcal enterotoxin A by human T cells bearing receptors with the Vγ9 region. Nature 1990, 346:572-574.
101. Sachse S., Seidel P., Gerlach D., Günther E., Rodel J., Straube E., Schmidt K.H. Superantigen-like gene(s) in human pathogenic Streptococcus dysgalactiae, subspecies equisimilis: genomic localization of the gene encoding streptococcal pyrogenic exotoxin G [spe(G) dys)]. FEMS Immunol. Med. Microbiol. 2002, 34:159-167.
102. Sawitzke A., Joyner D., Knudson K., Mu H.H., Cole B. Anti-MAM antibodies in rheumatic disease: evidence for a MAM-like superantigen in rheumatoid arthritis?. J. Rheumatol. 2000, 27:358-364.
103. Schafer R., Sheil J.M. Superantigens and their role in infectious diseases. Adv. Pediatr. Infect. Dis. 1995, 10:369-390.
104. Scholl P.R., Diez A., Karr R., Sekay J., Trowsdale J., Geha R.S. Effects of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules. J. Immunol. 1989, 144:226-230.
105. Shio M.T., Ribeiro-Dias F., Timenetsky J., Jancar S. PAF is involved in the Mycoplasma arthritidis superantigen-triggering pathway for iNOS and COX-2 expression in murine peritoneal cells. Exp. Cell Res. 2004, 298:296-304.
106. Smoot J.C., Barbian K.D., Van Gompel J.J., Smoot L.M., Chaussee M.S., Sylva G.L., Sturdevant D.E., Ricklefs S.M., Porcella S.F., Parkins L.D., Beres S.B., Campbell D.S., Smith T.V., Zhang Q., Kapur V., Daly J.A., Veasy L.G., Musser J.M. Genome sequence and comparative microarray analysis of serotype M18 group A streptococcus strains associated with acute rheumatic fever outbreaks. Proc. Natl. Acad. Sci. USA. 2002, 99:4668-4673.
107. Smoot L.M., McCormick J.K., Smoot J.C., Hoe N.P., Strickland I., Cole R.L., Barbian K.D., Earhart C.A., Ohlendorf D.H., Veasy L.G., Hill H.R., Leung D.Y., Schlievert P.M., Musser J.M. Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks. Infect. Immun. 2002, 70:7095-7104.
108. Sriskandan S., Moyes D., Cohen J. Detection of circulating bacterial superantigen and lymphotoxinα in patients with streptococcal toxic shock syndrome. The Lancet 1996, 348:1315-1316.
109. Stauffer Y., Marguerat S., Meylan F., Ucla C., Sutkowski N., Huber B., Pelet T., Conrad B. Interferon alpha-induced endogenous superantigen: a model linking environment and autoimmunity. Immunity 2001, 15:591-601.
110. Stevens D.L. Invasive group A streptococcus infections. Clin. Infect. Dis. 1992, 14:2-13.
111. Sundberg E.J., Li H., Llera A.S., McCormick J.K., Tormo J., Schlievert P.M., Karjalainen K., Mariuzza R.A. Structures of two streptococcal superantigens bound to TCR chains reveal diversity in the architecture of T cell signaling complexes. Structure 2002, 10:687-699.
112. Sutkowski N., Conrad B., Chen G., Calderon G, Huber B.T. Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen. J. Virol. 2004, 78:7852-7860.
113. Takahashi M., Shinohara F., Takada H., Rikiishi H. Effects of superantigen and lipopolysaccharide on induction of CD80 through apoptosis of human monocytes. Infect. Immun. 2001, 69:3652-3657.
114. Tomai M.A., Schlievert P.M., Kotb M. Distinct T cell receptor Vβ usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pepM5 protein. Infect. Immun. 1992, 60:701-705.
115. Uchiyama T., Imanishi K., Saito S., Araake M., Yan X.J., Fujikawa H., Igarashi H., Kato H., Obata F., Kashiwagi N., Inoko H. Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules. Eur. J. Immunol. 1989, 191:1803-1809.
116. Uchiyama T., Kamagata Y., Yan X.J., Kawachi H., Fujikawa H., Igarashi H., Okubo M. Relative strength of the mitogenic and interleukin-2 production-inducing activity of staphylococcal exotoxins presumed to be causative exotoxins of toxic shock syndrome toxin-1 and enterotoxins A, B, and C to murine and human T cells. Clin. Exp. Immunol. 1989, 75:239-244.
117. Uchiyama T., Yan X.-J., Imanishi K., Yagi Y. Bacterial superantigens: mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases. Microbiol. Immunol. 1994, 38:245-256.
118. Ulrich R.G., Bavari S., Olson M.A. Bacterial superantigens in human diseases: structure, function, and diversity. Trends Microbiol. 1995, 3:463-468.
119. Watanabe-Ohnishi R., Low D.E., McGeer A., Stevens D.L., Schlievert P.M., Newton D., Schwartz B., Kreiswirth B., et al. Selective depletion of Vβ bearing T cells in patients with severe group A streptococcal infections and streptococcal toxic shock syndrome. J. Infect. Dis. 1995, 171:74-84.
120. White J., Herman A., Pullen M., Kubo R., Kappler J.W., Marrack P. The Vβ specific superantigen staphylococcal enteroxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989, 56:27-35.
121. Wirth S., Vessaz A., Krummenacher C., Baribaud F., Acha-Orbea H., Diggelmann H. Regions of mouse mammary tumor virus superantigen involved in interaction with the major histocompatibility complex class II I-A molecule. J. Virol. 2000, 76:1172-1175.
122. Zollner T.M., Munk M.E., Keller T., Nuber V., Boehnke W.H., Kaufmann S.H.E., Duijvesijn A.M., Sterry W., Kaufmann R. The superantigen exfoliative toxin induces cutaneous lymphocyte-associated antigen expression in peripheral human T lymphocytes. Immunol. Lett. 1996, 49:111-116.